Enhanced External Counterpulsation and Its Effects on Vascular Hemodynamics in Cognitively Impaired Patients
Status: | Completed |
---|---|
Conditions: | Cognitive Studies |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - 85 |
Updated: | 4/21/2016 |
Start Date: | June 2012 |
End Date: | October 2014 |
The aim of this study is to investigate whether enhanced external counterpulsation (EECP)
therapy for 7 consecutive weeks will improve cerebral blood flow and possibly over time
enhance or slow down breakdown of cognitive function in patients diagnosed with mild
cognitive impairment (MCI).
therapy for 7 consecutive weeks will improve cerebral blood flow and possibly over time
enhance or slow down breakdown of cognitive function in patients diagnosed with mild
cognitive impairment (MCI).
Inclusion Criteria:
- An adult between 18 and 85 years of age.
- Has been evaluated to have a CDR (Clinical Dementia Rating) Score of 0.5
- Male or female (if female must be postmenopausal for at least 1 year, surgically
sterile or using an effective form of contraception).
- Able to speak and read English.
- Willing to comply with study specific instructions, and complete all study procedures
according to protocol.
- Able to understand study rationale and sign informed consent.
Exclusion Criteria:
- Diagnosed with glaucoma
- History of developing adverse effects to ophthalmic dilating agents (phenylephrine or
tropicamide).
- Currently taking warfarin and dabigatran (Pradaxa).
- History of having arrhythmias - can interfere with EECP triggering.
- Subject has bleeding diathesis.
- Subject has active thrombophlebitis.
- Subject has severe lower extremity vaso-occlusive disease.
- Subject has a documented aortic aneurysm requiring surgical repair.
- Subject is pregnant.
- Subject with blood pressure higher than 180/110 mmHg.
- Subject with a heart rate more than 120 bpm.
- Subject with high risk of complications from increased venous return.
- Subject with clinically significant valvular disease.
- Subjects with severe vascular disease as established by the Hachinski Ischemic Index.
- Subjects with pacemakers and other metallic implantable devices.
We found this trial at
1
site
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
Click here to add this to my saved trials